Integra LifeSciences Holdings Corporation · NASDAQ:IART
Integra LifeSciences — Merger or Acquisition (January 2017)
7 slides from Integra LifeSciences's merger presentation, Jan 11, 2017
Slide 1: Integra LifeSciences Acquisition of Derma Sciences
Integra LifeSciences Acquisition of Derma Sciences January 11, 2017 Ex99.2
Slide 2: Safe Harbor / Non-GAAP Financial Measures
Safe Harbor / Non-GAAP Financial Measures This presentation contains “forward-looking statements”, including statements regarding the proposed transaction and the ability to consummate the proposed transaction. Statements in this document may contain, in addition to historical information, certain f
Slide 3: Derma Sciences Overview
Derma Sciences Overview Business Description Key Products Strategic Rationale Public company (NASDAQ: DSCI), located in Princeton, NJ; manufacturing operations in Toronto, China & Memphis A tissue regeneration company focused on advanced wound and burn care offering a line of products with patented
Slide 4: Integra 3x3 US Wound Care Strategy
INTEGRA 3x3 US Wound Care Strategy 3 Product Families First Company to Offer 3 Products through 3 Channels for Advanced Wound Care 3 Channels Strategy Products for multiple wound types and severity Multiple Clinical Options Inpatient Broad product range serving all of a system’s facilities allows fo
Slide 5: Product Portfolio Overview
Advanced Wound Care TCC & MediHoney Traditional Wound Care Advanced Wound Care Amniotic & Placental Product Portfolio Overview ~50% of Revenue Gross Margins ~58% Direct Sales Organizations in the US, UK and Canada Distributors ROW Mid-to-high Single digits growth ~25% of Revenue Gross Margin ~85% Di
Slide 6: Derma Sciences Transaction Summary
Derma Sciences Transaction Summary Integra will acquire the shares of Derma Sciences for $7 per share in cash at closing, ~$200M purchase price Subject to customary closing conditions (see details in concurrent Form 8-K filing) Expect to close acquisition late first quarter with cash from existing c
Slide 7: Acquisition Summary
Acquisition Summary Acquisition of Derma Sciences is a strong strategic fit Builds out our 3x3 strategy with addition of amniotic and placental tissue products Leverages existing sales channel with complementary advanced wound care products Accelerates our channel expansion in outpatient wound care
Integra Lifesciences Holdings — Merger or Acquisition (January 2017) on 6ix